Skip to Content

CYPAR MILK THISTLE CAPSULES

Active substance(s): MILK THISTLE DRY EXTRACT

View full screen / Print PDF » Download PDF ⇩
Transcript
a company of

Certification Mark

Patient Information Leaflet

Cypar

®

Milk Thistle Capsules

Mockup GB 01P0615 151 3811/01

capsules
Milk thistle standardised fruit extract

1. What this product is and what it is used for
This product is a traditional herbal medicinal
product containing milk thistle standardised fruit
extract.
Cypar ®  Milk Thistle Capsules is a traditional her­
bal medicinal product used to relieve the symp­
toms associated with occasional overindulgence
of food and drink such as indigestion and upset
stomach based on traditional use only.
2. Before you take this product
Do not take this product if:
– You are pregnant or breastfeeding
– You are allergic to any of the ingredients or to
plants of the Asteraceae/Compositae family
such as daisies, marigolds or artichokes (see
section 6)
– You are under 18 years of age
Tell your doctor before taking this product if you
are currently suffering from active liver disease.

Please read this leaflet carefully before you start
taking these capsules. It contains some important
information about Cypar ® Milk Thistle Capsules.
Keep this leaflet with the capsules. You may want
to read it again or show it to your doctor, pharma­
cist or qualified healthcare practitioner.
What is in this leaflet
1. What this product is and what it is used for
2. Before you take this product
3. How to take this product
4. Possible side effects
5. How to store this product
6. Further information
1

3. How to take this product
Adults and the elderly.
Take one capsule up to twice daily. Swallow the
capsule whole with some water or other liquid.
Capsules should not be chewed.
Do not exceed the stated dose.
Do not give this product to children or adolescents under 18 years old.
If you take too much of this product (overdose)
If you take more than the recommended dose,
speak to a doctor, pharmacist or qualified health­
care practitioner and take this leaflet with you.
2

Bezeichnung:

GI Cypar® Milk Thistle Capsules

Größe:

Inhalt:

30 Kapseln

Material:

Artikel-Nr.:

566113

Teile-Nr.:

Mockup

Druck-Kennz.:

01P0615

Laetus-Code:

(151)

EAN-Code:

Druckfarbe/
Winkelung bei
einer
Rasterweite
von 150 lpi

210 x 148 mm

Schwarz

45 °

If you have any questions, or are unsure about
anything, please ask your doctor, pharmacist
or qualified healthcare practitioner.
If your symptoms worsen or persist after one
week or if side effects become serious or if
you experience any side effects not mentioned in section 4 of this leaflet, consult your
doctor or qualified healthcare practitioner.
4. Possible side effects
Like all medicines, this product can have side ef­
fects.
The following side effects have been reported:
– Nausea (feeling sick), upset stomach, diar­
rhoea and headache
If these persist for more than a few days or
become more troublesome, stop taking the
­
­product. The side effects are usually only tempo­
rary.
– allergic reactions such as itching and/or skin
rash, urticaria, hives, pruritus, anaphylaxis
If you experience an allergic skin reaction stop
taking the product immediately.
Reporting of side effects
If you get any side effects, talk to your doctor or
pharmacist. This includes any possible side ef­
3

Lackaussparung:

Datum: 15.06.2015 Versions-Nr.: 00-0

Sachbearbeiter G+G

Verwendete Schriften:

I)-

Prüfung und Freigabe Köln:

Björn Sund

VAG Rounded

II)-

q Frei

überprüft durch:

Helvetica

III)-

Andreas Ueberschär
q Neuer Abzug erforderlich
Prüfung und Freigabe Berlin:
q Frei

PZN-Code:
Land:

If you forget to take this product
Continue to take your usual dose at the usual
time, it does not matter if you have missed a dose.

Geprüft durch PPC:
q Ja

q Nein

EAN lesbar:
England

q Neuer Abzug erforderlich

q Ja

q Nein

Seite: 1 von 2

fects not listed in this leaflet. You can also report
side effects directly via the Yellow Card Scheme,
Website: www.mhra.gov.uk/yellowcard. By re­
porting side effects you can help provide more in­
formation on the safety of this medicine

(equivalent to 3.725 
g 
– 
10.818 
g of milk thistle
fruits). This amount of standardised extract
corresponds to 108 mg of silymarin, calculated as
silibinin. Extraction solvent: Acetone 95 % v/v.

Manufacturer of this product
Klosterfrau Berlin GmbH
Motzener Strasse 41
12277 Berlin
Germany

5. How to store this product
Do not use your capsules after the expiry date.
The expiry date refers to the last day of that
month.
The expiry date is printed on the box and the blis­
ter pack.

This product also contains the following
ingredients:
Extract excipient:
Mannitol
Capsule contents:
Mannitol, cellulose microcrystalline, crosscarmel­
lose sodium, silica colloidal anhydrous, magnesi­
um stearate.
Capsule shell:
Gelatin, purified water, titanium dioxide (E 171),
sodium laurylsulfate, iron (III)-oxide (E 172) (red
iron oxide), iron oxide hydrate (E 172) (yellow iron
oxide).

Traditional herbal registration number:
THR 29860/0007

Each pack contains 30 or 60 hard capsules. The
capsules are red opaque.

This leaflet was prepared in May 2015.

Medicines should not be disposed of via waste­
water or household waste. Ask your pharmacist
how to dispose of medicines no longer required.
These measures will help to protect the environ­
ment.

Mockup GB 01P0615 151 3811/01

Do not store above 25° C.
Store in original package.
Keep your capsules out of the reach and sight of
children.
Keep your capsules in the blister pack until it is
time to take them.
6. Further information
Each hard capsule contains 193 mg – 261 mg of
standardised extract (as dry extract) from milk
thistle fruits (Silybum marianum (L.) Gaertner)

4

Registration holder for this product
Cassella-med GmbH & Co.KG
Gereonsmuehlengasse 1
50670 Cologne
Germany

GI Cypar® Milk Thistle Capsules

Größe:

Inhalt:

30 Kapseln

Material:

Artikel-Nr.:

566113

Teile-Nr.:

Mockup

Druck-Kennz.:

01P0615

Laetus-Code:

(151)

EAN-Code:

Druckfarbe/
Winkelung bei
einer
Rasterweite
von 150 lpi

210 x 148 mm

Schwarz

For a large print, Braille or audio version
of this leaflet, call Ceuta Healthcare Ltd.
on 08006527150

6

45 °

Lackaussparung:

Datum: 15.06.2015 Versions-Nr.: 00-0

Sachbearbeiter G+G

Verwendete Schriften:

I)-

Prüfung und Freigabe Köln:

Björn Sund

VAG Rounded

II)-

q Frei

überprüft durch:

Helvetica

III)-

Andreas Ueberschär
q Neuer Abzug erforderlich
Prüfung und Freigabe Berlin:
q Frei

PZN-Code:
Land:

Telephone: 01202 780558
Fax: 01202 780559
Email.: info@ceutahealthcare.com

Cassella-med GmbH is a company of the

5

Bezeichnung:

If you would like further information about this
product, please contact:
Ceuta Healthcare Ltd.,
41 Richmond Hill,
BOURNEMOUTH BH2 6HS,
United Kingdom.

Geprüft durch PPC:
q Ja

q Nein

EAN lesbar:
England

q Neuer Abzug erforderlich

q Ja

q Nein

Seite: 2 von 2

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide